XML 114 R96.htm IDEA: XBRL DOCUMENT v3.25.2
Stock-Based Compensation - Narrative (Detail) - USD ($)
12 Months Ended
Sep. 27, 2023
Apr. 27, 2025
Apr. 28, 2024
Apr. 30, 2023
Sep. 16, 2015
Time Based Restricted Stock Units [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Remaining unrecognized compensation cost   $ 561,000      
Weighted average period over which unrecognized compensation cost is expected to be recognized   1 year 4 months 24 days      
Fair value of units expected to vest   $ 1,000,000.0      
Performance Based Restricted Stock Units [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Remaining unrecognized compensation cost   $ 13,000      
Weighted average period over which unrecognized compensation cost is expected to be recognized   1 year 2 months 12 days      
Fair value of units expected to vest   $ 16,000      
Selling, General and Administrative Expenses [Member] | Time Based Restricted Stock Units [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based compensation expense   644,000 $ 823,000 $ 808,000  
Selling, General and Administrative Expenses [Member] | Performance Based Restricted Stock Units [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based compensation expense   $ 6,000 8,000 2,000  
Selling, General and Administrative Expenses [Member] | Common Stock Awards [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based compensation expense     $ 84,000 $ 335,000  
2015 Equity Incentive Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of common stock authorized for issuance         1,200,000
Amended and Restated Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of common stock authorized for issuance additional 960,000        
Number of shares available for future equity based grants   668,353